BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 126 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,922,394 | +4.9% | 1,542,711 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $10,410,675 | +10.8% | 1,478,789 | +31.2% | 0.00% | 0.0% |
| Q1 2023 | $9,396,728 | -27.7% | 1,126,706 | -0.4% | 0.00% | -33.3% |
| Q4 2022 | $12,991,847 | -29.8% | 1,131,694 | -23.0% | 0.00% | -25.0% |
| Q3 2022 | $18,511,000 | +27.1% | 1,469,155 | +6.7% | 0.00% | +33.3% |
| Q2 2022 | $14,566,000 | -29.7% | 1,376,712 | +8.1% | 0.00% | -25.0% |
| Q1 2022 | $20,709,000 | +83.8% | 1,273,625 | +56.5% | 0.00% | +100.0% |
| Q4 2021 | $11,270,000 | +2.2% | 813,660 | +6.0% | 0.00% | 0.0% |
| Q3 2021 | $11,031,000 | -13.9% | 767,695 | -5.2% | 0.00% | -33.3% |
| Q2 2021 | $12,809,000 | -42.0% | 810,162 | -62.7% | 0.00% | -50.0% |
| Q1 2021 | $22,075,000 | +875.9% | 2,170,590 | +614.9% | 0.01% | +500.0% |
| Q4 2020 | $2,262,000 | -55.2% | 303,635 | -79.3% | 0.00% | 0.0% |
| Q3 2020 | $5,050,000 | -52.4% | 1,469,940 | -33.9% | 0.00% | -66.7% |
| Q2 2020 | $10,600,000 | +261.9% | 2,224,672 | +51.9% | 0.00% | +200.0% |
| Q1 2020 | $2,929,000 | -24.4% | 1,464,540 | +30.4% | 0.00% | 0.0% |
| Q4 2019 | $3,875,000 | +29.7% | 1,123,279 | +7.7% | 0.00% | 0.0% |
| Q3 2019 | $2,987,000 | -21.6% | 1,042,631 | +3.7% | 0.00% | 0.0% |
| Q2 2019 | $3,812,000 | +22.1% | 1,005,707 | +162.2% | 0.00% | 0.0% |
| Q1 2019 | $3,122,000 | +150.6% | 383,614 | +148.3% | 0.00% | – |
| Q4 2018 | $1,246,000 | +13.1% | 154,511 | +7.0% | 0.00% | – |
| Q3 2018 | $1,102,000 | +94.7% | 144,468 | +46.2% | 0.00% | – |
| Q2 2018 | $566,000 | +18.2% | 98,794 | -1.6% | 0.00% | – |
| Q1 2018 | $479,000 | -46.8% | 100,409 | -45.3% | 0.00% | – |
| Q4 2017 | $901,000 | -68.8% | 183,643 | -66.7% | 0.00% | – |
| Q3 2017 | $2,890,000 | -52.9% | 551,537 | -50.0% | 0.00% | -100.0% |
| Q2 2017 | $6,131,000 | -7.3% | 1,102,757 | +40.0% | 0.00% | -50.0% |
| Q1 2017 | $6,616,000 | -3.5% | 787,689 | -27.3% | 0.00% | 0.0% |
| Q4 2016 | $6,858,000 | +73.4% | 1,083,440 | +20.8% | 0.00% | +100.0% |
| Q3 2016 | $3,955,000 | +21.5% | 896,742 | -21.8% | 0.00% | 0.0% |
| Q2 2016 | $3,255,000 | -7.1% | 1,146,080 | -7.4% | 0.00% | 0.0% |
| Q1 2016 | $3,502,000 | -69.4% | 1,237,418 | +11.8% | 0.00% | -75.0% |
| Q4 2015 | $11,427,000 | -5.0% | 1,107,285 | +5.0% | 0.00% | 0.0% |
| Q3 2015 | $12,024,000 | -22.0% | 1,054,770 | +2.1% | 0.00% | -20.0% |
| Q2 2015 | $15,425,000 | +65.4% | 1,033,164 | +0.1% | 0.01% | +66.7% |
| Q1 2015 | $9,325,000 | +196.7% | 1,032,568 | +299.5% | 0.00% | +200.0% |
| Q4 2014 | $3,143,000 | +402.9% | 258,475 | +304.4% | 0.00% | – |
| Q3 2014 | $625,000 | -87.5% | 63,917 | -83.7% | 0.00% | -100.0% |
| Q2 2014 | $4,992,000 | +1689.2% | 391,508 | +1386.3% | 0.00% | – |
| Q1 2014 | $279,000 | -62.8% | 26,341 | -73.3% | 0.00% | – |
| Q4 2013 | $751,000 | -44.2% | 98,802 | -46.6% | 0.00% | – |
| Q3 2013 | $1,346,000 | +319.3% | 184,941 | -10.6% | 0.00% | – |
| Q2 2013 | $321,000 | +1295.7% | 206,775 | +1196.8% | 0.00% | – |
| Q4 2012 | $23,000 | -72.3% | 15,945 | -18.7% | 0.00% | – |
| Q3 2012 | $83,000 | -56.1% | 19,612 | -58.8% | 0.00% | – |
| Q2 2012 | $189,000 | – | 47,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |